We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+4.76%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$13.4B
AUM Growth
+$1.43B
Cap. Flow
+$857M
Cap. Flow %
6.4%
Top 10 Hldgs %
14.37%
Holding
602
New
156
Increased
172
Reduced
106
Closed
146

Top Buys

Rank Stock Value
1
TXN icon
Texas Instruments
TXN
+$175M
2
LOW icon
Lowe's Companies
LOW
+$167M
3
AZO icon
AutoZone
AZO
+$127M
4
NTRS icon
Northern Trust
NTRS
+$127M
5
MRK icon
Merck
MRK
+$118M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$133M
2
RAI
Reynolds American Inc
RAI
+$126M
3
KEY icon
KeyCorp
KEY
+$113M
4
WMT icon
Walmart Inc
WMT
+$110M
5
OA
Orbital ATK, Inc.
OA
+$108M

Sector Composition

Rank Sector Weight
1 Technology 16.72%
2 Industrials 14.06%
3 Consumer Discretionary 12.07%
4 Healthcare 11.22%
5 Financials 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARE icon
151
Alexandria Real Estate Equities
ARE
$8.73B
$26.5M 0.2%
222,684
+35,689
+19% +$4.29M
SPN
152
DELISTED
Superior Energy Services, Inc.
SPN
$26.4M 0.2%
247,643
-273,324
-52% -$27M
IPOA.U
153
DELISTED
Social Capital Hedosophia Holdings Corp.
IPOA.U
$26.4M 0.2%
+2,500,000
New +$26.3M
LOGM
154
DELISTED
LogMein, Inc.
LOGM
$26.3M 0.2%
239,112
-252,760
-51% -$28.3M
FNSR
155
DELISTED
Finisar Corp
FNSR
$26.1M 0.2%
1,179,301
-1,462,315
-55% -$35.8M
SRPT icon
156
Sarepta Therapeutics
SRPT
$1.68B
$26M 0.19%
+573,440
New +$22.9M
JBHT icon
157
JB Hunt Transport Services
JBHT
$25.6B
$25.5M 0.19%
+229,839
New +$22.2M
PXD
158
DELISTED
Pioneer Natural Resource Co.
PXD
$25.4M 0.19%
171,902
+34,342
+25% +$4.94M
UNH icon
159
UnitedHealth
UNH
$375B
$25.1M 0.19%
128,360
+66,316
+107% +$12.8M
USWS
160
DELISTED
U.S. Well Services, Inc. Class A Common Stock
USWS
$24.7M 0.18%
120,224
+14
+0% +$2.85K
VAR
161
DELISTED
Varian Medical Systems, Inc.
VAR
$24.6M 0.18%
+245,919
New +$25.2M
MXIM
162
DELISTED
Maxim Integrated Products
MXIM
$24.4M 0.18%
+512,007
New +$23.5M
FG
163
DELISTED
FGL Holdings Ordinary Shares
FG
$24.3M 0.18%
2,168,496
+611,124
+39% +$6.72M
PCRX icon
164
Pacira BioSciences
PCRX
$979M
$24M 0.18%
638,943
-322,680
-34% -$13M
OVV icon
165
Ovintiv
OVV
$16B
$23.7M 0.18%
402,337
+373,549
+1,298% +$18.3M
KSU
166
DELISTED
Kansas City Southern
KSU
$23.6M 0.18%
+217,361
New +$22.8M
USFD icon
167
US Foods
USFD
$22.1B
$23.4M 0.17%
875,000
-432,615
-33% -$11.9M
PRTK
168
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$23M 0.17%
916,349
+756,535
+473% +$17.6M
OXFD
169
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$22.8M 0.17%
1,355,529
+413,904
+44% +$6.74M
LAUR icon
170
Laureate Education
LAUR
$5.24B
$22.7M 0.17%
1,562,135
+536,982
+52% +$8.42M
CVE icon
171
Cenovus Energy
CVE
$51.1B
$22.2M 0.17%
+2,218,257
New +$18.1M
TRTX
172
TPG RE Finance Trust
TRTX
$610M
$22.1M 0.16%
+1,116,499
New +$22.1M
RRR icon
173
Red Rock Resorts
RRR
$3.56B
$21.7M 0.16%
936,660
-238,340
-20% -$5.51M
EGN
174
DELISTED
Energen
EGN
$21.7M 0.16%
396,708
+184,416
+87% +$9.39M
HSY icon
175
Hershey
HSY
$36.1B
$21M 0.16%
+192,421
New +$20.5M

Similar funds

Alyeska Investment Group's Q3 2017 Portfolio in Review

As of Q3 2017, Alyeska Investment Group held 602 positions worth $13.4B, up 12% from $12B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Alyeska Investment Group deployed $857M of net new capital in Q3 2017, opening 156 new positions and adding to 172 existing holdings. Its largest new stake was AutoZone: 238,293 shares worth $142M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was AbbVie, an estimated $133M trimmed.

  • Alyeska Investment Group's largest Q3 2017 buy was AutoZone: 238,293 shares worth $142M.
  • Alyeska Investment Group added most to Texas Instruments in Q3 2017, an estimated $175M increase.
  • Alyeska Investment Group's biggest Q3 2017 reduction was AbbVie, cutting an estimated $133M.
  • Alyeska Investment Group fully exited Reynolds American Inc in Q3 2017, selling an estimated $126M.
  • Alyeska Investment Group's ten largest holdings make up 14% of its $13.4B portfolio in Q3 2017.
  • Alyeska Investment Group opened 156 new positions and closed 146 in Q3 2017.
  • Alyeska Investment Group's portfolio value rose 12% quarter-over-quarter to $13.4B.

Based on Alyeska Investment Group's 13F filing for Q3 2017, filed 14 Nov 2017.